Normothermic versus hypothermic cardiopulmonary bypass in low-risk paediatric heart surgery: a randomised controlled trial.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
03 2019
Historique:
received: 08 05 2018
revised: 16 07 2018
accepted: 15 08 2018
pubmed: 17 10 2018
medline: 3 5 2019
entrez: 17 10 2018
Statut: ppublish

Résumé

To compare normothermic (35°C-36°C) versus hypothermic (28°C) cardiopulmonary bypass (CPB) in paediatric patients undergoing open heart surgery to test the hypothesis that normothermic CPB perfusion maintains the functional integrity of major organ systems leading to faster recovery. Two single-centre, randomised controlled trials (known as In total, 200 participants were recruited; 59 to the Normothermic CPB is as safe and effective as hypothermic CPB and can be routinely adopted as a perfusion strategy in low-risk infants and children undergoing open heart surgery. ISRCTN93129502.

Identifiants

pubmed: 30322847
pii: heartjnl-2018-313567
doi: 10.1136/heartjnl-2018-313567
pmc: PMC6580777
doi:

Substances chimiques

Lipocalin-2 0
Creatinine AYI8EX34EU
Serum Albumin, Human ZIF514RVZR

Banques de données

ISRCTN
['ISRCTN93129502']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-464

Subventions

Organisme : British Heart Foundation
ID : CH/17/1/32804
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1992027/7163
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800800
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/33/31394
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur J Cardiothorac Surg. 1999 Nov;16(5):540-5
pubmed: 10609905
Neurochem Res. 2000 Oct;25(9-10):1439-51
pubmed: 11059815
Ann Thorac Surg. 2005 Sep;80(3):982-8
pubmed: 16122470
Eur J Cardiothorac Surg. 2006 Nov;30(5):695-9
pubmed: 17010633
J Thorac Cardiovasc Surg. 2007 Jan;133(1):241-6
pubmed: 17198820
Neurocrit Care. 2007;6(2):121-38
pubmed: 17522796
Ann Thorac Surg. 2009 Feb;87(2):489-95
pubmed: 19161766
Pediatr Crit Care Med. 2010 Mar;11(2):234-8
pubmed: 19794327
J Thorac Cardiovasc Surg. 1991 Feb;101(2):269-74
pubmed: 1992237
Artif Organs. 2010 Apr;34(4):E91-102
pubmed: 20420605
Eur J Cardiothorac Surg. 2011 Dec;40(6):1384-90
pubmed: 21752665
J Thorac Cardiovasc Surg. 2011 Nov;142(5):1114-21, 1121.e1-2
pubmed: 21872282
Ann Thorac Surg. 2013 Sep;96(3):923-9
pubmed: 23915588
N Engl J Med. 2014 Jul 10;371(2):140-9
pubmed: 25006720
JMIR Res Protoc. 2015 May 25;4(2):e59
pubmed: 26007621
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1063-1064
pubmed: 28502619
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1056-1062
pubmed: 28599970
Lancet. 1994 Mar 5;343(8897):559-63
pubmed: 7906327
J Thorac Cardiovasc Surg. 1997 Sep;114(3):475-81
pubmed: 9305202

Auteurs

Massimo Caputo (M)

Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Katie Pike (K)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Sarah Baos (S)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Karen Sheehan (K)

Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Kathleen Selway (K)

Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Lucy Ellis (L)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Serban Stoica (S)

Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Andrew Parry (A)

Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Gemma Clayton (G)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Lucy Culliford (L)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Gianni D Angelini (GD)

Bristol Heart Institute, University of Bristol, Bristol, UK.

Ragini Pandey (R)

Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Chris A Rogers (CA)

Clinical Trials and Evaluation Unit, Bristol Trials Centre, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH